Stephens Increases The Pennant Group (NASDAQ:PNTG) Price Target to $32.00

The Pennant Group (NASDAQ:PNTGFree Report) had its price target boosted by Stephens from $28.00 to $32.00 in a research report sent to investors on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock.

PNTG has been the topic of a number of other research reports. Royal Bank of Canada lifted their target price on The Pennant Group from $21.00 to $26.00 and gave the company an outperform rating in a research report on Thursday, May 9th. Oppenheimer lifted their target price on The Pennant Group from $28.00 to $34.00 and gave the company an outperform rating in a research report on Thursday. Finally, Truist Financial lifted their price target on The Pennant Group from $25.00 to $28.00 and gave the company a hold rating in a research note on Monday, July 15th.

Check Out Our Latest Stock Report on The Pennant Group

The Pennant Group Stock Performance

Shares of The Pennant Group stock traded up $1.52 on Thursday, hitting $30.29. The stock had a trading volume of 214,080 shares, compared to its average volume of 166,709. The Pennant Group has a twelve month low of $10.31 and a twelve month high of $31.23. The business’s 50 day moving average is $25.47 and its two-hundred day moving average is $21.48. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $910.09 million, a price-to-earnings ratio of 56.09, a price-to-earnings-growth ratio of 3.17 and a beta of 2.00.

The Pennant Group (NASDAQ:PNTGGet Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15. The business had revenue of $156.92 million for the quarter, compared to the consensus estimate of $146.01 million. The Pennant Group had a return on equity of 13.42% and a net margin of 2.86%. Analysts forecast that The Pennant Group will post 0.73 EPS for the current year.

Hedge Funds Weigh In On The Pennant Group

Several institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC lifted its stake in The Pennant Group by 17.1% in the second quarter. Renaissance Technologies LLC now owns 267,300 shares of the company’s stock valued at $6,199,000 after buying an additional 39,000 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in shares of The Pennant Group by 17.1% during the second quarter. Oppenheimer Asset Management Inc. now owns 17,486 shares of the company’s stock valued at $406,000 after acquiring an additional 2,549 shares in the last quarter. Federated Hermes Inc. increased its holdings in shares of The Pennant Group by 600.0% during the second quarter. Federated Hermes Inc. now owns 54,045 shares of the company’s stock valued at $1,253,000 after acquiring an additional 46,324 shares in the last quarter. ClariVest Asset Management LLC increased its holdings in shares of The Pennant Group by 12.3% during the second quarter. ClariVest Asset Management LLC now owns 98,641 shares of the company’s stock valued at $2,287,000 after acquiring an additional 10,791 shares in the last quarter. Finally, Rhumbline Advisers increased its holdings in shares of The Pennant Group by 8.9% during the second quarter. Rhumbline Advisers now owns 44,239 shares of the company’s stock valued at $1,026,000 after acquiring an additional 3,611 shares in the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Further Reading

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.